Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at tamoxifen or anastrozole in postmenopausal women with ductal carcinoma in situ of the breast (IBIS II DCIS)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at 2 hormone therapy drugs called tamoxifen and anastrozole after surgery for ductal carcinoma in situ (DCIS). It was for women who had been through the and had DCIS. This trial was supported by Cancer Research UK.

Recruitment start: 3 March 2003

Recruitment end: 8 February 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jack Cuzick

Professor Antony Howell

Professor John Forbes

Supported by

Cancer Research UK

NIHR Clinical Research Network: Cancer

Queen Mary University of London

Other information

This is Cancer Research UK trial number CRUK/04/032/033.

Last reviewed: 25 February 2016

CRUK internal database number: 228

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.